Breadcrumb Home Business Activities Lundbeckfonden BioCapital Lundbeckfonden BioCapital Portfolio Vesper Biotechnology Vesper Biotechnology Vesper Biotechnology is a preclinical biotech company developing treatments based on Vps10p-protein to target various therapeutic indications. Related news about Vesper Biotechnology Lundbeck Foundation doubles its investment in Aarhus-based Insusense Therapeutics Lundbeckfonden BioCapital Invested 2012 Seed Financing Location Aarhus, Denmark Investors Lundbeckfonden BioCapital Contact Paul Little Operating Partner pl@lundbeckfonden.com Kevin Dalgaard Principal kdd@lundbeckfonden.com Mobile +45 3013 5365